RT @RHEUMarampa: ð¸DM pts who are anti-TIF-1 Ab+ have higher risk of malignancy ð¸Ovarian cancer - most common Reall

Article Drug Safety

Neoplasia and Autoimmune Disease

Jack Cush, MD Apr 27, 2026

Malignancy rivals cardiovascular disease as a leading cause of death in patients with systemic autoimmune diseases. Chronic inflammation and immune dysregulation can drive oncogenesis, while antitumor immune responses can trigger autoimmune phenomena (paraneoplastic syndromes, checkpoint inhibitor-induced rheumatic disease).

Article General Rheumatology

Screening High Risk Myositis Patients for Cancer

Jack Cush, MD Apr 13, 2026

An Italian retrospective study of 411 idiopathic inflammatory myopathies (IIM) patients applied IMACS criteria to assess the risk of cancer and found significantly more cancers in those at high risk.